查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498736

个人化医疗市场，按产品、按应用、按最终用户和按地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Personalized Medicine Market, By Product, By Application, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年个人化医疗市场规模为 5,719.562 亿美元，2024 年至 2032 年复合年增长率为 8.00%。

个人化医疗市场-市场动态

越来越多的人患有慢性病，推动市场成长

慢性病几乎是每个国家的全球主要议题。全世界有许多人因治疗一种或多种慢性疾病而遭受痛苦。根据美国癌症研究协会 (AACR) 的预测，到 2040 年，仅在美国就会发现超过 230 万个新癌症病例。癌症病例；然而，实际发生率预计将高出 1.5 至 3 倍。此外，据世界卫生组织 (WHO) 称，全球估计有 4.22 亿人患有糖尿病，每年导致 150 万人死亡。在过去的几十年中，糖尿病的发生率和盛行率逐渐增加。因此，糖尿病、癌症等慢性疾病病例的不断增加预计将在预测期内推动对个人化医疗的需求。

个人化医疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.00% 左右的复合年增长率成长

根据产品细分，个人化医疗诊断类别预计将在 2023 年呈现最大市场份额

从应用细分来看，肿瘤学类别是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

个人化医疗市场-細項分析：

全球个人化医疗市场根据产品、应用、最终用户和地区进行细分。

市场依产品分为两类：个人化医学诊断（基因检测、DTC诊断等）及个人化医学治疗（药品、基因组医学、医疗器材）。由于糖尿病、癌症和心血管疾病等慢性疾病的成本不断上升，以及对识别这些疾病的个人化医疗诊断的需求随之增加，个人化医疗诊断类别在市场上占据主导地位。此外，随着越来越多的个人和医疗保健专业人员意识到先进的个人化医疗选择，该市场正在不断增长。

根据最终用户，市场分为以下几类：医院和临床护理、诊断公司和测试设施、学术研究所和研究实验室、合约研究组织、生物和健康资讯公司等。医院和临床护理类别在市场中占据主导地位，并可能在预测期内保持其主导地位。在整个预期期间推动该细分市场成长的主要成长因素之一是，由于糖尿病、癌症、心血管疾病和其他疾病等慢性疾病的盛行率不断上升，医院对个人化医疗的需求不断增长。此外，有利的报销方案以及发展中国家医疗保健投资的增加推动了个人化医疗市场的不断成长。

个人化医疗市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

在预测期内，预计北美将占据全球个人化医疗市场的最大份额。大型製药公司和研究机构对此表示支持。新药物的发现和对某些疾病的研究是相关的，因为目前建议个人化治疗来治疗多种疾病。用于诊断目的的客製化医疗领域最近取得了进展。例如，2021 年 1 月，Illumina, Inc. 创建了 TruSight Oncology 500 (TSO 500) 检测方法，可以使用肿瘤区域的核酸有效识别多达 523 种癌症生物标记。

此外，预计亚太地区的个人化医疗市场将以全球最快的速度扩张。该地区慢性病发病率的上升和老年人口的增加正在推动市场的扩张。此外，在整个预测期内，亚洲国家研发投资的增加、医疗保健支出的增加、医疗保健意识的提高以及新诊断技术的采用预计将推动整个地区的市场扩张。

个人化医疗市场-竞争格局：

全球个人化医疗市场由许多致力于扩大市场份额的大大小小的公司组成。该行业可能具有一定的竞争性。由于治疗慢性疾病（包括糖尿病、癌症和其他疾病）对个人化医疗的需求不断增长，预计市场将在整个预测期内迅速扩张。 GE Healthcare、Illumina, Inc.、Abbott、Dako A/S 和 International Business Machines Corporation (IBM) 等製药公司积极参与客製化医疗领域，正在加速将基因组资讯转化为有用的患者治疗方法。此外，重要的联盟和伙伴关係、技术进步以及新产品的推出可能将在未来几年支持市场扩张。

最近的发展：

2023 年 9 月：当路德维希癌症研究所的研究人员将 ACT 与客製化的癌症疫苗结合使用时，晚期卵巢癌患者获得了更好的结果。令人惊讶的是，17 名患者中有 12 名在接受联合药物治疗三个月后病情得到控制。这意味着治疗有效地控制了疾病。

2023 年 6 月：在核子医学和分子影像学会 (SNMMI) 2023 年年会上，GE 医疗展示了最新的尖端技术和诊断技术。 GE HealthCare 强调了治疗诊断学，这是一种将客製化医学与诊断影像相结合的新颖策略。

2023年2月：埃森哲透过埃森哲创投公司对尖端人工智慧和科技新创公司Ocean Genomics进行了大量策略性投资。总部位于匹兹堡的 Ocean Genomics 开发了先进的工具来建模和理解 mRNA 变异和变化。由于这项技术，现在可以更准确地预测患者对药物的生物反应。

目录

第一章：个人化医疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 个人化医疗市场片段（按产品）
    • 按应用分类的个人化医疗市场片段
    • 最终用户的个人化医疗市场片段
    • 按国家/地区分類的个人化医疗市场摘要
    • 按地区分類的个人化医疗市场片段
  • 竞争洞察

第 3 章：个人化医疗主要市场趋势

  • 个性化医疗市场驱动因素
    • 市场驱动因素的影响分析
  • 个人化医疗市场限制
    • 市场限制影响分析
  • 个人化医疗市场机会
  • 个人化医疗市场未来趋势

第 4 章：个人化医疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：个人化医疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：个人化医疗市场格局

  • 个人化医疗市场占有率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：个人化医疗市场 - 按产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 个性化医疗诊断
      • 基因检测
      • 故障码诊断
      • 其他的
    • 个人化医学治疗
      • 製药
      • 基因组医学
      • 医疗设备

第 8 章：个人化医疗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肿瘤学
    • 神经病学
    • 心臟病学
    • 抗病毒剂
    • 精神病学
    • 免疫学
    • 其他的

第 9 章：个人化医疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和临床护理
    • 诊断公司和检测设施
    • 学术研究所和研究实验室
    • 合约研究组织
    • 生物与健康资讯公司
    • 其他的

第 10 章：个人化医疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美个人化医疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲个人化医疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区个人化医疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲个人化医疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲个人化医疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 个人化医疗产业

  • 竞争仪表板
  • 公司简介
    • GE Healthcare
    • Illumina, Inc.
    • Abbott
    • Dako A/S
    • International Business Machines Corporation (IBM)
    • Genelex
    • ASURAGEN, INC.
    • Danaher Corporation (Cepheid, Inc.)
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.
    • Exact Sciences Corporation
    • Celera Diagnostics LLC.
    • Biogen
    • Precision Biologics
    • Genentech, Inc.
    • 23andMe, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2905

REPORT HIGHLIGHT

Personalized Medicine Market size was valued at USD 5,71,956.2 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.

Treatment that is tailored to each patient's unique physiognomies is known as personalized medicine. With a focus on patient data, customized medications, sophisticated analytics, and the understanding and management of diseases, personalized medicine has great potential to shift and transform the healthcare sector. Science and technology are evolving, particularly in the areas of disease description, medication development, and treatment recommendation in personalized medicine. The idea of personalized medicine has surfaced in the last ten years as a result of growing breakthroughs in genomic and proteomic science. These advancements have fueled the creation of targeted diagnostics and therapeutics that use an individual's genetic makeup to create a more individualized approach to healthcare.

Personalized Medicine Market- Market Dynamics

Growing Numbers of People are Suffering from Chronic Illnesses to Propel Market Growth

Chronic illnesses are becoming a major global concern in practically every nation. Numerous people worldwide experience suffering as a result of managing one or more chronic diseases. According to projections made by the American Association for Cancer Research (AACR), more than 2.3 million new cancer cases will be discovered in the US alone by the year 2040. Furthermore, according to a study conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), 19 to 20 lakh cases of cancer will be reported in India in 2022; however, the true incidence is predicted to be 1.5 to 3 times higher. Moreover, an estimated 422 million people worldwide are estimated to have diabetes, which causes 1.5 million deaths annually, according to the World Health Organization (WHO). Diabetes has gradually increased in incidence and prevalence during the last few decades. The growing cases of chronic illnesses such as diabetes, cancer, and so on is therefore anticipated to drive the demand for personalized medicine during the forecast period.

Personalized Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032)

Based on product segmentation, the personalized medicine diagnostics category was predicted to show maximum market share in the year 2023

Based on application segmentation, the oncology category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Personalized Medicine Market- Segmentation Analysis:

The Global Personalized Medicine Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into two categories based on product: Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Others) and Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices). The Personalized Medicine Diagnostics category dominates the market due to the rising cost of chronic illnesses, including diabetes, cancer, and cardiovascular disease, as well as the ensuing increase in demand for diagnostics in personalized medicine to identify these conditions. Additionally, the market is growing as more individuals and healthcare professionals become aware of advanced personalized medical options.

The market is divided into the following categories based on end-user: Hospitals And Clinical Care, Diagnostic Companies And Testing Facilities, Academic Research Institutes And Research Laboratories, Contract Research Organizations, Bio And Health Informatics Companies, and Others. The Hospitals And Clinical Care category dominates the market and is likely to maintain its dominance during the forecast period. One of the main growth factors propelling the segment's growth throughout the anticipated period is the rising need for personalized medicine in hospitals as a result of the rising prevalence of chronic diseases like diabetes, cancer, cardiovascular diseases, and other disorders. Additionally, the growing section of the personalized medicine market is being driven by advantageous reimbursement scenarios in conjunction with increased healthcare investments in developing nations.

Personalized Medicine Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for personalized medicine. Large pharmaceutical firms and research organisations have supported this. Discovery of new medications and study on certain ailments are connected since personalised therapy is presently recommended for treating many sorts of illnesses. There have been recent advancements in the field of customised medicine for diagnostic purposes. For instance, in January 2021, Illumina, Inc. created the TruSight Oncology 500 (TSO 500) assay, which can effectively identify up to 523 cancer biomarkers using nucleic acids from the tumor region.

In addition, the personalized medicine market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The rising incidence of chronic diseases and the growing senior population in the area are driving the market's expansion. Additionally, throughout the projection period, rising R&D investment among Asian countries, rising healthcare expenditures, a rise in healthcare awareness, and the adoption of new diagnostic techniques are anticipated to propel market expansion throughout the region.

Personalized Medicine Market- Competitive Landscape:

The global market for personalized medicine is made up of a number of big and small companies that are focusing on expanding their market share. The industry may be characterized as being somewhat competitive. Due to the growing need for personalized medicine in the treatment of chronic diseases, including diabetes, cancer, and other conditions, the market is anticipated to expand rapidly throughout the forecast period. Pharmaceutical companies such as GE Healthcare, Illumina, Inc., Abbott, Dako A/S, and International Business Machines Corporation (IBM), among others, have aggressive involvement in the customized medicine space is hastening the conversion of genomic information into useful patient treatments. Furthermore, significant alliances and partnerships, technological advancements, and the introduction of new goods are probably going to support market expansion in the years to come.

Recent Developments:

September 2023: Patients with advanced ovarian cancer had better results when researchers at the Ludwig Institute for Cancer Research paired ACT with a customized cancer vaccination. Surprisingly, 12 out of 17 patients experienced illness control after three months of receiving the combo medication. This implies that the treatment effectively managed the disease.

June 2023: At the 2023 annual conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), GE HealthCare showcased new and cutting-edge technologies and diagnostics. Theranostics, a novel strategy that combines tailored medicine with diagnostic imaging, was highlighted by GE HealthCare.

February 2023: Through Accenture Ventures, Accenture made a sizable strategic investment in Ocean Genomics, a cutting-edge AI and technology startup. Pittsburgh-based Ocean Genomics has created advanced tools for modeling and comprehending mRNA variations and alterations. A patient's biological reaction to a medication can now be predicted with greater accuracy because of this technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Illumina, Inc.

Abbott

Dako A/S

International Business Machines Corporation (IBM)

Genelex

ASURAGEN, INC.

Danaher Corporation (Cepheid, Inc.)

Decode Genetics, Inc.

QIAGEN

Exagen Inc.

Exact Sciences Corporation

Celera Diagnostics LLC.

Biogen

Precision Biologics

Genentech, Inc.

23andMe, Inc.

Others

GLOBAL PERSONALIZED MEDICINE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Personalized Medicine Diagnostics
  • Genetic Testing
  • DTC Diagnostics
  • Others
  • Personalized Medicine Therapeutics
  • Pharmaceutical
  • Genomic Medicine
  • Medical Devices

GLOBAL PERSONALIZED MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Antiviral
  • Psychiatry
  • Immunology
  • Others

GLOBAL PERSONALIZED MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals And Clinical Care
  • Diagnostic Companies And Testing Facilities
  • Academic Research Institutes And Research Laboratories
  • Contract Research Organizations
  • Bio And Health Informatics Companies
  • Others

GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Personalized Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Personalized Medicine Market Snippet by Product
    • 2.1.2. Personalized Medicine Market Snippet by Application
    • 2.1.3. Personalized Medicine Market Snippet by End User
    • 2.1.4. Personalized Medicine Market Snippet by Country
    • 2.1.5. Personalized Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Personalized Medicine Key Market Trends

  • 3.1. Personalized Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Personalized Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Personalized Medicine Market Opportunities
  • 3.4. Personalized Medicine Market Future Trends

4. Personalized Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Personalized Medicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Personalized Medicine Market Landscape

  • 6.1. Personalized Medicine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Personalized Medicine Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Personalized Medicine Diagnostics
      • 7.1.2.1. Genetic Testing
      • 7.1.2.2. DTC Diagnostics
      • 7.1.2.3. Others
    • 7.1.3. Personalized Medicine Therapeutics
      • 7.1.3.1. Pharmaceutical
      • 7.1.3.2. Genomic Medicine
      • 7.1.3.3. Medical Devices

8. Personalized Medicine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Neurology
    • 8.1.4. Cardiology
    • 8.1.5. Antiviral
    • 8.1.6. Psychiatry
    • 8.1.7. Immunology
    • 8.1.8. Others

9. Personalized Medicine Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals And Clinical Care
    • 9.1.3. Diagnostic Companies And Testing Facilities
    • 9.1.4. Academic Research Institutes And Research Laboratories
    • 9.1.5. Contract Research Organizations
    • 9.1.6. Bio And Health Informatics Companies
    • 9.1.7. Others

10. Personalized Medicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Personalized Medicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Personalized Medicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Personalized Medicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Personalized Medicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Personalized Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Personalized Medicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
    • 11.2.2. Illumina, Inc.
    • 11.2.3. Abbott
    • 11.2.4. Dako A/S
    • 11.2.5. International Business Machines Corporation (IBM)
    • 11.2.6. Genelex
    • 11.2.7. ASURAGEN, INC.
    • 11.2.8. Danaher Corporation (Cepheid, Inc.)
    • 11.2.9. Decode Genetics, Inc.
    • 11.2.10. QIAGEN
    • 11.2.11. Exagen Inc.
    • 11.2.12. Exact Sciences Corporation
    • 11.2.13. Celera Diagnostics LLC.
    • 11.2.14. Biogen
    • 11.2.15. Precision Biologics
    • 11.2.16. Genentech, Inc.
    • 11.2.17. 23andMe, Inc.
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Medicine Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Personalized Medicine Market, by Product 2019-2032 (USD Million)
  • TABLE Personalized Medicine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Personalized Medicine Market, by Application 2019-2032 (USD Million)
  • TABLE Personalized Medicine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Personalized Medicine Market, by End User 2019-2032 (USD Million)
  • TABLE Personalized Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Market, by End User, 2019-2032 (USD Million)